Elizabeth Holmes, former Theranos CEO, begins 11-year jail sentence for defrauding investors.

Theranos, once valued at $10 billion, exposed as a cautionary tale of startup culture. 

Theranos' revolutionary blood testing claims proved inaccurate, leading to downfall 

Investigation reveals Theranos' false positives for conditions like cancer and HIV 

Wall Street Journal reporter John Carreyrou uncovers Theranos' fraudulent practices 

Elizabeth Holmes found guilty of defrauding investors, not patients 

Theranos' COO Ramesh Balwani also convicted in the fraud case 

Lessons learned: The importance of due diligence in the biotech industry